Latest News & Press

March 16, 2022
March 15, 2022
February 15, 2022
At 4D Path, we aim to revolutionize cancer diagnostics. Our patented, end-to-end statistical physics and tumor biology platform unveils hidden data and tissue phenotypes. This approach underpins biomarker typing and prognostication from H&E images, and strives to meet the needs of pathologists, oncologists, and patients.